Log Type Authored on Log Message Log Node Authored by
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Melhora do presenteísmo no TDM – sintomas cognitivos e funcionalidade Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened CONVITE LUNDBECK - Temporada de atualizações em TDM com os mais renomados especialistas internacionais – RESERVE SUA VAGA Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
OWA Status Wed, 10/12/2022 - 13:23 Updating trust level from 1 to 2 Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Atualize-se com a Progress in Mind Brazil Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Convite Exclusivo Stahl e McIntyre - Tratamento do TDM com resposta insatisfatória aos antidepressivos Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
Log Type Authored on Log Message Log Node Authored by
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Melhora do presenteísmo no TDM – sintomas cognitivos e funcionalidade Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened CONVITE LUNDBECK - Temporada de atualizações em TDM com os mais renomados especialistas internacionais – RESERVE SUA VAGA Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
OWA Status Wed, 10/12/2022 - 13:23 Updating trust level from 1 to 2 Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Atualize-se com a Progress in Mind Brazil Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Convite Exclusivo Stahl e McIntyre - Tratamento do TDM com resposta insatisfatória aos antidepressivos Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous